Company / Shares Outstanding
NeoGenomics Laboratories, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
128.1M
FY2025
5-year range
120.0M / 128.1M
FY2021-FY2025
Trend
+1.1%
vs FY2024
Sector context
#67 of 165
Health Care
What the data says
At 128101000.00, NeoGenomics Laboratories, Inc.'s shares outstanding ranks #99 of 165 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 75820307.00 in FY2016 to 128101000.00 in FY2025.
Based on SEC 10-K filings.
128101000.00 in FY2025 with a 5-year CAGR of +2.8%.
Increased from 125502000.00 to 128101000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- +2.8%
- 10-Year CAGR
- -
Sector benchmark
#99 of 165 in Health CareTop 59% of 165This company 128.1M Sector average 170.1M
▼
-24.7% below sector average
Key checks
Key Insights
- NeoGenomics Laboratories, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 1.1% year-over-year.
- Ranks #67 out of 165 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 128.1M | +1.1% |
| FY2024 | 126.7M | +0.9% |
| FY2023 | 125.5M | +1.0% |
| FY2022 | 124.2M | +3.5% |
| FY2021 | 120.0M | +7.3% |
| FY2020 | 111.8M | +7.9% |
| FY2019 | 103.6M | +13.2% |
| FY2018 | 91.6M | +16.5% |
| FY2017 | 78.6M | +3.6% |
| FY2016 | 75.8M | +25.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026